The MarketWatch News Department was not involved in the creation of this content.
Pune, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) —
Pune, Oct. 08, 2020 (GLOBE NEWSWIRE) — The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors. According to a report published by Fortune Business Insights, titled “Immunology Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 77,365.4 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.
Highlights of the Report:
- Analysis of the impact of Covid-19 that the market would face in the near future.
- In-depth analysis of the growth drivers and obstacles.
- Profile of all the companies operating in the market.
- Elaborate data about the dominating region.
- Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657
Recent Product Approvals by Regulatory Agencies to Bode Well for the Overall Market
The spate of recent regulatory approvals for the immunology products is anticipated to contribute to the overall positive growth of the market. For instance, the recent regulatory approval and the subsequent launch of TREMFYA (Guselkumab) by Janssen Global Services, LLC (Johnson & Johnson), is expected to lead to better outcome for the patients.
TREMFYA (Guselkumab) was launched for the treatment of moderate to severe plaque psoriasis, a seriously debilitating immunological disorder. TREMFYA is the only biologic approved for the treatment of moderate to severe plaque psoriasis, that selectively blocks the interleukin (IL)-23, leading to a vast improvement in the symptoms of the patient.
Apart from being one of the emerging drugs of the immunology market, Fortune Business Insights predicts that Janssen Global Services, LLC (Johnson & Johnson) latest product offering will have a positive impact on the global immunology market in the forthcoming years.
The global economy is in absolute turmoil because of the COVID-19 pandemic outbreak. Some industries remain largely unaffected by the outbreak, some are thriving, but most are in doldrums. Although the healthcare industry is flourishing, certain markets within the industry are experiencing staggered growth. Wading through these troubled times is a difficult task and Fortune Business Insights(TM) aims at equipping your business with the most comprehensive market insights, collated and analyzed by our expert and experienced research team.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/immunology-market-100657
AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time
The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of ‘SKYRIZI’.
The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.
Besides product launches and drug approvals, Fortune Business Insights assesses several other factors that have made significant growth contributions to the global immunology market. Companies are encouraged by the growing usage approvals by regulatory authorities across the world. Several company mergers and acquisitions have also accounted for growth of the global immunology market.
Quick Buy – Immunology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100657
List of Global Immunology Market Players:
- AbbVie Inc.
- Janssen Global Services, LLC (Johnson & Johnson)
- F. Hoffmann-La Roche Ltd
- Amgen Inc.
- Pfizer Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Merck Sharp & Dohme Corp.
- UCB SA
- Other Prominent Players
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunology-market-100657
Global Immunology Market Segmentation:
By Drug Class
? Monoclonal antibody (mAb)
? Fusion Proteins
? Polyclonal antibody (pAb)
By Disease Indication
? Rheumatoid Arthritis
? Psoriatic Arthritis
? Plaque Psoriasis
? Ankylosing Spondylitis
? Inflammatory Bowel Disease
? Prophylaxis of Organ Rejection
By Distribution Channel
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? North America (U.S., and Canada)
? Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
? Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
? Latin America (Brazil, Mexico, and the Rest of Latin America)
? Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/immunology-market-100657
Have a Look at Related Reports:
Ophthalmic Surgical Devices Market Share & Industry Analysis, By Surgery Type (Cataract Surgery Devices, Vitreoretinal Surgery Devices, Refractive Error Surgery Devices, Glaucoma Surgery Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026
Adult Diapers Market Share & Industry Analysis, By Product Type (Underwear & Briefs, Pads & Guards, and Drip Collectors & Bed Protectors), By Gender (Male and Female) By Distribution Channel (Institutional Sales, Retail Stores, and Online Channels) and Regional Forecast, 2019-2026
Influenza Medication Market Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
Hormonal Contraceptives Market Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026
Mobility Scooter Market Share & Industry Analysis, By Wheels (3 Wheels, 4 Wheels, and Others) End-user (Personal User and Institutional User) and Regional Forecast, 2019-2026
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights(TM)
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/immunology-market-9140
Is there a problem with this press release? Contact the source provider Comtex at [email protected]. You can also contact MarketWatch Customer Service via our Customer Center.
(C) Copyright 2020 GlobeNewswire, Inc. All rights reserved.
The MarketWatch News Department was not involved in the creation of this content.